Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company wholesales pharmaceutical products.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 2,100 | 3,810 | 3,511 | 3,007 | 4,480 | 2,807 | 3,858 | +10.7% | |
| 875 | 955 | 527 | 575 | 496 | 458 | 469 | -9.9% | |
| TOTAL ASSETS | 2,976 | 4,765 | 4,038 | 3,582 | 4,976 | 3,266 | 4,326 | +6.4% |
| 1,151 | 2,163 | 2,158 | 2,076 | 2,667 | 2,336 | 2,669 | +15.1% | |
| Total Non-Current Liabilities | 820 | 1,093 | 750 | 513 | 365 | 568 | 915 | +1.8% |
| TOTAL LIABILITIES | 1,970 | 3,256 | 2,908 | 2,588 | 3,031 | 2,904 | 3,584 | +10.5% |
| 1,005 | 1,510 | 1,130 | 994 | 1,944 | 362 | 742 | -4.9% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||||
| Total Debt | 926 | 1,196 | 750 | 513 | 365 | 568 | 915 | -0.2% |
| Cash & Equivalents | 31 | 12 | 11 | 28 | 16 | 1 | 17 | -9.3% |
| Net Debt | 896 | 1,184 | 739 | 484 | 348 | 567 | 897 | +0.0% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →